“Are we detecting re-infection or failure of treatment?”
The incidence of hepatitis C re-infection among high-risk individuals who
have spontaneously cleared the infection may be higher than previously assumed,
a modelling study published in the May 1st edition of the Journal
of Infectious Diseases suggests.
The study has implications for the design of a hepatitis C vaccine and more
immediately for prevention campaigns. It also has implications for assumptions
about rates of sustained virological response after completion of hepatitis C
therapy, Prof. Jason Grebeley of the Kirby Institute, University
of New South Wales, one of the authors
of the study, told delegates at the International Liver Congress in Barcelona.